Abstract
Infections of the urinary tract are common problems encountered in primary care and specialty care practice. There are an estimated seven to eight million physician visits for acute uncomplicated urinary tract infections and more than one million hospitalizations annually in the United States [1]. They account for over US$1 billion in health care costs annually in the United States [2]. This figure would be much higher if other costs were included such as laboratory tests, outpatient-therapy, and missed days from work or school. Women are more afflicted by urinary tract infections compared to men except at the extremes of age. Indeed, urinary tract infections are the most frequent bacterial infection in women. Approximately half of adult women report an experience with urinary tract infection at some point in their lives [3]. Of women who experience an initial infection, 25–30% will have recurrent episodes [4]. Women with recurrent urinary tract infections account for a significant portion of referrals to gynecologists, urologists, and urogynecologists.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Gorbach SL, Bartlett JG, Falagas M, Damer DH. Guidelines for Infectious Diseases in Primary Care. Baltimore, MD: Williams & Wilkins, 1999.
Kunin CM. Urinary tract infections in females. Clin Infect Dis 1994;18:1–12.
Kunin CM. Urinary Tract Infections, 5th edn. Baltimore, MD: Williams & Wilkins, 1997.
Hooton TM. Recurrent urinary tract infections in women. Int J Antimicrob Agents 2001;17:259–68.
Foxman B, Frerichs RR. Epidemiology of urinary tract infections: I Diaphragm use and sexual intercourse. Am J Public Health 1985;75:1308.
Health Indicators 1999 CD-ROM, Statistics Canada.
Romano JM, Jaye D. UTI in the elderly: common yet atypical. Geriatrics 1981;36:113–15.
Shortliffe LMD, Stamey TA. Urinary tract infections in adult women. In: Walsh PC, Gittes RE, Permufter AF et al., editors. Campbell’s Urology. Philadelphia: WS Saunders, 1986;797–830.
Abrutyn E, Biscia JA, Kaye D. The treatment of asymptomatic bacteriuria in the elderly. J Am Geriatr Soc 1988;36:473–5.
McCue JD. Effective treatment in the long-term care setting. Geriatrics 2000;55 (Sept):48–61.
Sourander LB. Urinary tract infection in the aged — an epidemiological study. Am Med Intern Fenn 1966;55(45):7–55.
Thiede HA. The prevalence of urogynecologic disorders. Obstet Gynecol Clin North Am 1989;16(4):709–16.
Foxman B, Somsel P, Sobel JD et al. Urinary tract infection among women aged 40–65: behavioral and sexual risk factors. J Clin Epidemiol 2001;54(7):710–18.
Maybeck CE. Treatment of uncomplicated urinary tract infection in nonpregnant women. Postgrad Med J 1972;48:69.
Kunin CM, McCormack RC. An epidemiologic study of bacteriuria and blood pressure among nuns and working women. N Engl J Med 1968;278:635.
Raz R, Gennesin Y, Wasser J et al. Recurrent urinary tract infections in post-menopausal women. Clin Infect Dis 2000;30:152–6.
Raz R. Postmenopausal women with recurrent UTI. Int J Antimicrob Agents 2001;17:269–71.
Ronald AR, Harding GKM. Complicated urinary tract infections. Infect Dis Clin North Am 1997;11(3):583–593.
Hooton TM, Stamm WE. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am 1997;11:551–81.
McCarty JM, Richard G, Huck W et al. A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin Urinary Tract Infection Group. Am J Med 1999;106:292–9.
Stamm WE, Counts GW, Running KR et al. Diagnosis of coliform infection in acutely dysuric women. N Engl J Med 1982;307:463–8.
Bartlett RC, O’Neill D, McLaughlin JC. Detection of bacteriuria by leukocyte esterase, nitrite, and the Automicrobic System. Am J Clin Pathol 1984;82:683–7.
Semeniuk H, Church D. Evaluation of the leukocyte esterase and nitrite urine dipstick screening tests for detection of bacteriuria in women with suspected uncomplicated urinary tract infections. J Clin Microb 1999;37(9):3051–2.
Leibovici L, Wysenbeek AJ. Single-dose antibiotic treatment for symptomatic urinary tract infections in women: a metaanalysis of randomized trials. Q J Med 1991;285:43.
Norrby SR. Short-term treatment of uncomplicated lower urinary tract infections in women. Rev Infect Dis 1990;12:458.
Hooton TM. Practice guidelines for urinary tract infection in the era of managed care. Int J Antimicrob Agents 1999;11:241–5.
Warren JW, Abrutyn E, Stamm WE et al. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis 1999;29:745–58.
Iravani A, Klimberg I, Echold RM et al. A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection. J Antimicrob Chemother 1999;43(Suppl A):67–75.
Gupta K, Hooton TM, Stamm WE. Increasing antimicrobial resistance under the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med 2001;135:41–50.
Mazulli T, Skulnick M, Low DE et al. Susceptibility of community Gram negative urinary tract isolates to mecillinam and other oral agents. Presented 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, 24–27 September 1998. Abstract E-038.
Reckendorf HK, Castringius RG, Spingler HK. Comparative pharmacodynamics, urinary excretion, and half-life determinations of nitrofurantoin sodium. Antimicrob Agents Chemother 1962;2:531–7.
McCarty JM, Rishard G, Huck W et al. A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin Urinary Tract Infection Group. Am J Med 1999;106:292–9.
Gupta K, Scholes D, Stamm WE. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA 1999;281:736–8.
Dyer IE, Sankary TM, Dawson JA. Antibiotic resistance in bacterial urinary tract infections, 199–1997. West J Med 1988;169:265–8.
Gupta K, Sahm DF, Mayfield D, Stamm WE. Antimicrobial resistance among uropathogens causing community acquired UTI in women: a nationwide analysis. Clin Infect Dis. 2001;33(1):89–94.
Zhanel GG, Karlowsky JA, Harding GK et al. A Canadian national surveillance study of urinary tract isolates from outpatients: a comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. The Canadian Urinary Isolate Study Group. Antimicrob Agents Chemother 2000;44:1089–92.
Trienekens T, Stobberingh E, Beckers F, Knottnerus A. The antibiotic susceptibility patterns of uropathogens isolated from general practice patients in southern Netherlands. J Antimicrob Chemother 1994;33:1064–6.
Gruneberg RN. Changes in urinary pathogens and their antibiotic sensitivities, 1971–1992. J Antimicrob Chemother 1994;33(Suppl A):1–8.
Perrin M, Donnio PY, Heurtin-Lecorre C et al. Comparative antimicrobial resistance and genomic diversity of Escherichia coli isolated from urinary tract infections in the community and in hospitals. J Hosp Infect 1999;41:273–9.
Weber G, Risenberg K, Schlaeffer F et al. Changing trends in frequency and antimicrobial resistance of urinary pathogens in outpatient clinics and a hospital in Southern Israel, 1991–1995. Eur J Clin Microbiol Infect Dis 1997;16:834–8.
Christaens TH, Heytens S, Verschraegen G et al. Which bacteria are found in women with uncomplicated urinary tract infections in primary health care, and what is their susceptibility pattern anno 95–96? Acta Clin Belg 1998;53:184–8.
Orrett FA, Shurland SM. The changing patterns of antimicrobial susceptibility of urinary pathogens in Trinidad. Singapore Med J 1998;39:256–9.
Iqbal J, Rahman M, Kabir MS, Rahman M. Increasing ciprofloxacin resistance among prevalent urinary tract bacterial isolated in Bangladesh. Jpn J Med Sci Biol 1997;50:241–50.
Garcia-Rodriguez JA. Bacteriological comparison of cefixime in patients with noncomplicated urinary tract infection in Spain. Preliminary results. Chemotherapy 1998;44(Suppl 1):28–30.
Safrin S, Siegel D, Black D. Pyelonephritis in adult women: inpatient versus outpatient therapy. Am J Med 1988;85:793–8.
Pinson AG, Philbrick JT, Lindbeck, Schorling JB. ED management of acute pyelonephritis in women: a cohort study. Am J Emerg Med 1994;12:271–8.
Stamm WE, McKevitt M, Counts GW. Acute renal infection in women: treatment with trimethoprim-sulfamethoxazole or ampicillin for two or six weeks. Ann Intern Med 1987;106:341–5.
Jernelius H, Zbornik J, Bauer CA. One or three weeks’ treatment of acute pyelonephritis? A double blind comparison, using a fixed combination of pivampicillin plus pivmecillinam,. Acta Med Scand 1988;223:469–77.
Bergeron MG. Treatment of pyelonephritis in adults. Med Clin North Am 1995;79:619–49.
Bach D, van den Berg-Segers A, Hubner A et al. Rufloxacin once daily versus ciprofloxacin twice daily in the treatment of patients with acute uncomplicated pyelonephritis. J Urol 1995;154:19–24.
Bailey RR, Peddie BA. Treatment of acute urinary tract infection in women. Ann Intern Med 1987;107:430.
Talen D, Stamm WE, Reuning-Scherer J, Church D. Ciprofloxacin (CIP) 7 day vs. TMP/SMX 14 day +/− ceftriaxone (CRO) for acute uncomplicated pyelonephritis: a randomized, double-blind trial. Boston: International Congress of Infectious Diseases, 1988.
Ronald AR, Nicolle LE, Harding GKM. Standard of therapy for urinary tract infections in adults. Infection 1992;20(Suppl 3):S164–70.
Melekos MD, Naber KG. Complicated urinary tract infections. Int J Antimicrob Agents 2000;15:247–56.
Stamm WE. Catheter-associated urinary tract infections: epidemiology, pathogenesis, and prevention. Am J Med 1991;91(Suppl 3B):S65–71.
Kawada Y. Comparison of complicated urinary tract infections in men and women. Infection 1994;22(Suppl 1):S55–7.
Bailey RR, Lynn KL, Robson RA et al. DMSA renal scans in adults with acute pyelonephritis. Clin Nephrol 1996;46:99–104.
Johnson JR, Vincent LM, Wanf K et al. Renal ultrasonography correlates of acute pyelonephritis. Clin Infect Dis 1992;14:15–22.
Talner LB, Davidson AJ, Lebowitz RL et al. Acute pyelonephritis: can we agree on terminology? Radiology 1994;192:297–305.
Gillenwater JY. The pathophysiology of urinary tract obstruction. In: Walsh PC, Retik AB, Stamey TA, Vaughan ED, editors. Campbell’s Urology. Philadelphia: Saunders, 1992;299–332.
Schaeffer JA. Infections of the urinary tract. In: Walsh PC, Retik AB, Stamey TA, Vaughan ED, editors. Campbell’s Urology. Philadelphia: Saunders, 1992;731–806.
Weidner W, Ludwig M, Weimar B et al. Rational diagnostic steps in acute pyelonephritis with special reference to ultrasonography and computed tomography scan. Int J Antmicrob Agents 1999;11:257–9.
Stamey TA. Pathogenesis and Treatment of Urinary Tract Infections. Baltimore, MD: Williams & Wilkins, 1980.
Huland H, Busch R. Chronic pyelonephritis as a cause of end-stage renal disease. J Urol 1982;127:642–3.
Sklar AH, Caruana RJ, Lammers JE, Strauser GD. Renal infections in autosomal dominant polycystic kidney disease. Am J Kidney Dis 1987;10:81–8.
Nicolle LE. Asymptomatic bacteriuria in the elderly. Infect Dis Clin North Am 1997;11:647–67.
Schaeffer AJ, Rajan N, Cao Q et al. Host pathogenesis in urinaryntract infections. Int J Antimicrob Agents 2001;17:245–51.
Brandtzaeg P. Mucosal immunity in the female genital tract. J Reprod Immunol 1997;36:23–50.
Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993;329:753–6.
Eriksen BC. A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women. Am J Obstet Gynecol 1999;180:1072–9.
Warren JW. Catheter-associated urinary tract infections. Infect Dis Clin North Am 1997;11(3):609–22.
Mulhall AB, Chapman RG, Crow RA. Bacteriuria during indwelling urethral catheterisation. J Hosp Infect 1988;11:253–62.
Ramsay JWA, Garnham AJ, Mulhall AB et al. Biofilms, bacteria and bladder catheters. A clinical study. Br J Urol 1989;64:395–8.
Zimmerli W, Lew PD, Waldvogel FA. Pathogenesis of foreign body infection. Evidence for local granulocyte defect. J Clin Invest 1984;73:1191–200.
Rahav G, Pinco E, Silbaq F et al. Molecular epidemiology of catheter-associated bacteriuria in nursing home patients. J Clin Microbiol 1994;32:1031–4.
Warren JW, Tenney JH, Hoopes JM et al. A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J Infect Dis 1982;146:719–23.
Warren JW. Catheter-associated urinary tract infections. Int J Antimicrob Agents 2001;17:299–303.
Mobley HLT, Warren JW. Urease-positive bacteriuria and obstruction of long-term urinary catheters. J Clin Microbiol 1987;25:2216–17.
Jacobs L, Skidmore E, Freeman K et al. Oral fluconazole compared with bladder irrigation with amphotericin B for treatment of fungal urinary tract infections in elderly patients. Clin Infect Dis 1996;22:30–5.
Patterson JE, Andriole VT. Bacterial urinary tract infections in diabetes. Infect Dis Clin N Am 1997;11(3):735–49.
Botalla MA, Baladimos MC, Bradley RF. Bacteriuria in diabetes mellitus. Diabetologia 1971;7:297–301.
Stamey TA, Kaufman MF. Studies of introital colonization in women with recurrent urinary infections. II. A comparison of growth in normal vaginal fluid of common versus uncommon serogroups of Escherichia coli. J Urol 1975;114:264–7.
Schaeffer AJ, Jones JM, Dunn JK. Association of in vitro Escherichia coli adherence to vaginal and buccal epithelial cells with susceptibility of women to recurrent urinary-tract infections. N Engl J Med 1981;304:1062–6.
Scholes D, Hooton TM, Roberts PL et al. Risk factors for recurrent UTI in young women. J Infect Dis 2000;182:1177–82.
Hooton TM, Stapleton AE, Roberts PL et al. Perineal anatomy and urine-voiding characteristics of young women with and without recurrent urinary tract infections. N Engl J Med 1993;329:753–6.
Nicolle LE, Ronald AR. Recurrent urinary tract infection in adult women: diagnosis and treatment. Infect Dis Clin North Am 1987;1:793–806.
Ronald AR, Conway B. An approach to urinary tract infections in ambulatory women. Curr Clin Top Infect Dis 1988;9:76–125.
Hooton TM. Recurrent urinary tract infection in women. Int J Antimicrob Agents 2001;17:259–68.
Nicolle LE, Ronald AR. Recurrent urinary tract infection in adult women: diagnosis and treatment. Infect Dis Clin North Am 1987;1:793–806.
Nicolle LE. Prophylaxis: recurrent urinary tract infection in women. Infection 1992;20:5203–5.
Chew LD, Fihn SD. Recurrent cystitis in nonpregnant women. West J Med 1999;170:274–7.
Stapleton A, Latham RH, Johnson C, Stamm WE. Postcoital antimicrobial prophylaxis for recurrent urinary tract infection. J Infect Dis 1988;157:1239–41.
Foxman B, Geiger AM, Palm K et al. First-time urinary tract infection and sexual behaviour. Epidemiology 1995;6:162–8.
Avorn J, Monane M, Gurwitz, Gurwitz JH et al. Reduction of bacteriuria and pyuria after ingestion of cranberry juice. JAMA 1994;271:751–4.
Sobota AE. Inhibition of bacterial adherence by cranberry juice: potential use for the treatment of urinary tract infections. J Urol 1984:131;1013–16.
Schmidt DR, Sobota AW. An examination of the anti-adherence activity of cranberry juice on urinary and nonurinary bacterial isolates. Microbios 1988;55:173–81.
Ofek I, Goldhar J, Zafriri D et al. Anti-Escherichia adhesin activity of cranberry and blueberry juices. N Engl J Med 1991;324:1599.
Chan RCY, Bruce AW, Reid G. Adherence of cervical, vaginal and distal urethral normal microbial flora to human uroepithelial cells and the inhibition of adherence of gram-negative uropathogens by competitive exclusion. J Urol 1984;131:596–601.
Chan RCY, Reid G, Irwin RT et al. Competitive exclusion of uropathogens from human uroepithelial cells by Lactobacillus whole cells and cell wall fragments. Infect Immun 1985;47:84–9.
Klebanoff SJ, Hillier SL, Eschenbach DA et al. Control of microbial flora of the vagina by H2O2-generating lactobacilli. J Infect Dis 1991;164:94–100.
McGroarty JA, Reid G. Detection of a lactobacillus substance that inhibits Escherichia coli. Can J Microbiol 1988;34:974–8.
McGroarty JA, Reid G. Inhibition of enterococci by Lactobacillus species in vitro. Microb Ecol Health Dis 1988;1:215–19.
Stamm WE, Norrby SR. Urinary tract infections: disease panorama and challenges. J Infect Dis 2001;183(Suppl 1):S1–4.
Gentelet H, Carrricajo A, Rusch P et al. Evaluation of a new rapid urine screening analyzer: cell Facts. Pathol Biol 2001;49:262–4.
Gupta K, Hooton TM, Roberts PL, Stamm WE. Patient-initiated treatment of uncomplicated urinary tract infections in young women. Ann Intern Med 2001;135:9–16.
Langermann S, Ballou WR Jr. Vaccination utilizing the FimCH complex as a strategy to prevent Escherichia coli urinary tract infections. J Infect Dis 2001;183(Suppl 1):S84–6.
Kozlowski PA, Cu-Uvin S, Neutra MR et al. Mucosal vaccination strategies for women. J Infect Dis 1999;179(Suppl 3):S493–8.
Uehling DT, Hopkins WJ, Beierle LM et al. Vaginal mucosal immunization for recurrent urinary tract infection: extended phase II clinical trial. J Infect Dis 2001;183(Suppl 1):S81–3.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag London Limited
About this chapter
Cite this chapter
Satkunaratnam, A., Drutz, H.P. (2003). Urinary Tract Infections in the Non-pregnant Woman. In: Drutz, H.P., Herschorn, S., Diamant, N.E. (eds) Female Pelvic Medicine and Reconstructive Pelvic Surgery. Springer, London. https://doi.org/10.1007/1-84628-238-1_16
Download citation
DOI: https://doi.org/10.1007/1-84628-238-1_16
Publisher Name: Springer, London
Print ISBN: 978-1-84628-237-9
Online ISBN: 978-1-84628-238-6
eBook Packages: Springer Book Archive